Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA)
Switzerland
14729502.6
Filed on 2014-03-14
14729502.6
Filed on 2014-03-14
Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA)
Belgium
14729502.6
Filed on 2014-03-14
14729502.6
Filed on 2014-03-14
SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS
US Patent 10,493,087
Filed on 2017-08-24
Filed on 2017-08-24
Sialylation-Increasing Therapies For Diseases Associated With Oxidative Stress
European Patent
16714599.4
Filed on 2016-02-23
16714599.4
Filed on 2016-02-23
Sialylation-Increasing Therapies For Diseases Associated With Oxidative Stress
Canada
2979640
Filed on 2016-02-23
2979640
Filed on 2016-02-23
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
Patent Cooperation Treaty
PCT/US2017/030174
Filed on 2017-04-28
PCT/US2017/030174
Filed on 2017-04-28
Cannabinoid Receptor Mediating Compounds
Patent Cooperation Treaty
PCT/US2017/020250
Filed on 2017-03-01
PCT/US2017/020250
Filed on 2017-03-01
N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT
European Patent
16196935.7
Filed on 2008-05-30
16196935.7
Filed on 2008-05-30
Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins
United Kingdom
12710636.7
Filed on 2012-03-15
12710636.7
Filed on 2012-03-15